The SPAC Market in 2026: What's Left After the Bubble Burst
The SPAC story is one of the most dramatic boom-bust cycles in recent financial history. In 2020 and 2021, Special Purpose Acquisition Companies raised over $250 billion, with celebrities, athletes, and first-time sponsors launching vehicles to take private companies public. The pitch was irresistib
From Mania to Reckoning
The SPAC story is one of the most dramatic boom-bust cycles in recent financial history. In 2020 and 2021, Special Purpose Acquisition Companies raised over $250 billion, with celebrities, athletes, and first-time sponsors launching vehicles to take private companies public. The pitch was irresistible: SPACs offered faster, more certain access to public markets than traditional IPOs, with the ability to share forward financial projections that SEC rules prohibited in conventional offerings.
Then reality arrived. The vast majority of companies that went public via SPAC in 2020-2021 have traded well below their $10 deal price. High-profile disasters — from electric vehicle companies that had no revenue to healthcare firms that overstated their pipelines — destroyed billions in investor value. The SEC tightened regulations, making SPACs less attractive and more costly. Sponsor reputations were damaged, and many institutional investors swore off the product entirely.
Here is our take: the SPAC mania was a speculative bubble fueled by cheap money and FOMO, and the resulting destruction was both predictable and deserved. But the SPAC structure itself is not inherently broken. What was broken was the incentive structure that rewarded sponsors for doing deals — any deals — regardless of quality. The post-crash market has addressed many of these problems, and the SPACs being launched in 2025-2026 look fundamentally different from their bubble-era predecessors.
What Went Wrong: A Post-Mortem
The Sponsor Incentive Problem
The root cause of the SPAC bubble was the sponsor promote — typically 20% of the post-deal company given to the sponsor for a nominal investment. This created a massive asymmetry: sponsors earned enormous paydays even on mediocre deals, while public investors bore the performance risk.
A sponsor who raised a $200 million SPAC and completed a deal — any deal — would receive founder shares worth $40-50 million at the deal price. Even if the stock fell 50% post-merger, the sponsor still made $20-25 million on a minimal cash investment. This incentive structure rewarded deal completion over deal quality.
The Projection Problem
Unlike traditional IPOs, SPAC mergers allowed target companies to share financial projections with investors. This was marketed as an advantage — investors would have more information. In practice, it became a weapon of value destruction. Companies routinely shared wildly optimistic projections that they had no realistic chance of meeting. When actual results fell short, stocks crashed.
Research by Stanford and other institutions found that the average SPAC target missed its projected revenue by 30-40% and missed projected EBITDA by even more. The projections were not forecasts — they were sales materials.
The Redemption Arbitrage
Hedge funds and other sophisticated investors discovered a risk-free arbitrage in SPACs: buy shares at or below the $10 trust value, collect interest while the SPAC searched for a target, and redeem shares for $10+ if the deal was unappealing. This meant that SPACs often went into deals with much less cash than they had raised, forcing additional financing (PIPEs) and diluting the deal economics.
The average SPAC redemption rate during the bubble exceeded 80%, meaning that most of the capital raised never actually went to the target company. The "blank check" was mostly bounced checks.
The 2026 SPAC Landscape
Structural Reforms
The post-crash SPAC market has implemented significant reforms:
Reduced promotes: Many new SPACs offer sponsors 10-15% promotes instead of 20%, or tie promote vesting to post-deal stock performance. Some sponsors have committed to purchasing additional shares at market price alongside public investors, increasing their skin in the game.
Longer lock-ups: Sponsor shares are increasingly subject to extended lock-up periods (12-24 months post-deal) and earn-out provisions that require the stock to reach specified price targets before founder shares vest.
Enhanced disclosure: SEC rules adopted in 2024 require more detailed disclosure of conflicts of interest, dilution effects, and the fairness of deal terms. Projections must be accompanied by clear assumptions and sensitivity analyses.
De-SPAC accounting changes: New accounting rules treat SPAC warrants as liabilities rather than equity, increasing the complexity and cost of SPAC structures but improving transparency.
Deal Flow and Quality
SPAC deal activity has declined dramatically from bubble levels — and that is a good thing. The SPACs that are completing deals in 2025-2026 are generally targeting:
- Companies with real revenue and demonstrable unit economics
- Businesses in sectors where public market access through traditional IPOs is difficult
- Targets where the SPAC sponsor has genuine domain expertise and can add post-merger value
- Companies with enterprise values better matched to the SPAC's capital capacity
The median revenue of SPAC targets has increased significantly, while the median revenue multiple has decreased. Translation: companies going public via SPAC are more mature and less speculative than during the bubble.
Who Is Sponsoring
The sponsor landscape has shifted from celebrities and first-timers to experienced operators and sector-focused investors. The new generation of SPAC sponsors typically have:
- Deep expertise in the target sector
- Operating experience that they can contribute post-merger
- Significant personal capital at risk alongside public investors
- Realistic expectations about target quality and deal timelines
This is a meaningful improvement. A SPAC sponsored by a former CEO with 20 years in healthcare who is seeking to take a specific type of healthcare company public is fundamentally different from a celebrity-backed SPAC with no sector thesis.
Should Investors Participate?
The Pre-Deal SPAC
Before a SPAC announces a target, investing in a pre-deal SPAC is essentially a cash management trade. Your shares are backed by the trust account (typically invested in Treasury bills), you can redeem at approximately $10 per share if you do not like the proposed deal, and you hold warrants that provide optionality.
The risk is minimal: you earn roughly the risk-free rate on your capital with a free option on a potentially attractive deal. The cost is opportunity: your capital is parked in a low-return vehicle until a deal happens or the SPAC liquidates.
For investors with idle cash, pre-deal SPACs can be a reasonable parking spot. But do not fool yourself into thinking this is investing — it is a cash management strategy with an embedded option.
The De-SPAC Transaction
Evaluating a proposed SPAC merger requires the same rigor as evaluating any public market investment:
Evaluate the target company on its fundamentals: revenue, growth rate, unit economics, competitive position, management team. Ignore the projections unless they are independently validated.
Assess the deal terms: What is the implied enterprise value? How does it compare to public comps? What is the total dilution from sponsor shares, warrants, and PIPE investors? Many SPAC deals that look cheap on headline metrics are actually expensive when you account for full dilution.
Evaluate the sponsor: Does the sponsor have relevant expertise? Are they committed for the long term? What is their skin in the game? A sponsor with deep sector expertise and significant personal capital invested alongside you is far more likely to make good decisions than one who is collecting a promote and moving on.
Check the redemption dynamics: High redemption rates can indicate that sophisticated investors do not believe the deal is attractive. If 90% of public shares are redeemed, ask yourself why those investors chose to exit rather than participate.
Post-Merger SPAC Stocks
For investors interested in buying SPAC stocks after the merger is complete, the opportunity set has actually improved. Many post-merger SPACs trade at depressed valuations — not because the businesses are bad, but because the SPAC stigma has created a structural discount.
Companies that went public via SPAC in 2021-2022 and have subsequently demonstrated strong operating performance are often trading at significant discounts to comparable companies that went public through traditional IPOs. This "SPAC discount" can represent a genuine value opportunity for investors willing to do the work of identifying quality businesses underneath the damaged brand.
The Regulatory Outlook
The SEC has been active in regulating the SPAC market, and further changes are possible:
- Enhanced liability: Rules making SPAC sponsors and their advisors more liable for misleading projections are increasing accountability
- Disclosure requirements: More detailed disclosure of dilution, conflicts, and deal economics improves transparency for retail investors
- Fair value requirements: Requirements to disclose the fair value of sponsor promote and other deal terms help investors understand true deal economics
These regulatory changes are, in our view, unambiguously positive for investors. They increase transparency, improve accountability, and make it harder for poorly constructed deals to reach the market. The regulation is not killing SPACs — it is killing bad SPACs.
Alternatives to Consider
For investors who like the concept of taking companies public but are wary of the SPAC structure, consider:
Direct listings: Companies list their shares directly on an exchange without raising new capital. This approach is most suitable for companies that do not need additional funding and want price discovery without the costs and dilution of an IPO or SPAC.
Traditional IPOs: Despite their limitations, traditional IPOs provide more regulatory protection, underwriter due diligence, and institutional price-setting than SPACs.
Pre-IPO secondary markets: Investing in private companies through secondary transactions provides exposure to companies before they go public, regardless of the eventual public listing mechanism.
What This Means for Investors
The SPAC market in 2026 is smaller, quieter, and better. The tourists have left, the regulations have tightened, and the deals that are getting done are generally more disciplined than what we saw during the bubble.
Our recommendations:
Do not write off SPACs entirely. The structure has legitimate uses, particularly for companies in complex sectors where the SPAC sponsor's expertise and relationships add genuine value.
Be extremely selective. The improved quality of the average SPAC deal does not mean every SPAC deal is good. Apply the same fundamental analysis you would to any public market investment.
Focus on sponsor quality and alignment. This is the single most important factor. A great sponsor with significant skin in the game is your best protection against poor deal quality.
Consider post-merger opportunities. The SPAC stigma discount creates potential value for investors willing to evaluate businesses on their merits rather than their listing mechanism.
Ignore the projections. Base your analysis on actual financial performance, verifiable metrics, and conservative growth assumptions. If the deal only works with the sponsor's projections, it does not work.
The SPAC experiment taught the market an expensive lesson about incentive alignment, speculation, and the consequences of easy money. The survivors — both sponsors and investors — are better for it.
